Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Where is the help for me here?' Female domestic violence survivors' narratives of navigating and receiving secondary-care mental health services in the United Kingdom.

Women's health (London, England)·2025
Same author

Correction: Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes.

Journal of immunology (Baltimore, Md. : 1950)·2022
Same author

Lifting the lid on impact and peer review.

Brain and neuroscience advances·2021
Same author

"The expert and the patient": a discourse analysis of the house of commons' debates regarding the 2007 Mental Health Act.

Journal of mental health (Abingdon, England)·2020
Same author

Evidence for prereg posters as a platform for preregistration.

Nature human behaviour·2020
Same author

Deborah Doniach, a pioneer in the field of autoimmunity.

Nature reviews. Immunology·2020

Related Experiment Video

Updated: May 23, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Parasitic worms and inflammatory disease.

Anne Cooke1

  • 1Department of Pathology, University of Cambridge, Tennis Court Rd, Cambridge, UK. ac@mole.bio.cam.ac.uk

Current Opinion in Rheumatology
|April 17, 2012
PubMed
Summary

Parasitic worms can reduce inflammation by manipulating the host immune system. Research is identifying parasite molecules and mechanisms for potential new anti-inflammatory therapies.

Area of Science:

  • Immunology
  • Parasitology
  • Molecular Biology

Background:

  • Parasitic worms possess immune-evasion strategies.
  • Some parasitic mechanisms can reduce host inflammation.
  • Understanding these mechanisms offers therapeutic potential.

Purpose of the Study:

  • To review recent findings on parasite-mediated immune modulation.
  • To highlight parasite-derived molecules involved in anti-inflammatory responses.
  • To explore therapeutic applications for inflammatory diseases.

Main Methods:

  • Literature review of current research.
  • Analysis of studies on parasite-host immune interactions.
  • Identification of key parasite-derived molecules and their functions.

More Related Videos

Experimental Infection of Mice with the Parasitic Nematode Strongyloides ratti
10:12

Experimental Infection of Mice with the Parasitic Nematode Strongyloides ratti

Published on: January 17, 2025

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation
09:58

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation

Published on: June 5, 2012

Related Experiment Videos

Last Updated: May 23, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Experimental Infection of Mice with the Parasitic Nematode Strongyloides ratti
10:12

Experimental Infection of Mice with the Parasitic Nematode Strongyloides ratti

Published on: January 17, 2025

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation
09:58

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation

Published on: June 5, 2012

Main Results:

  • Parasites and their products can inhibit innate and adaptive immune responses.
  • Progress has been made in identifying immunomodulatory parasite molecules.
  • Mechanisms of immune interaction and modulation are being elucidated.

Conclusions:

  • Parasite-mediated immunomodulation holds promise for treating inflammatory disorders.
  • Further research is needed to characterize helminth biomodulators.
  • Understanding mechanisms will enable the development of synthetic analogues.